Eaton Peabody Laboratory, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02214, United States of America; Biomedical Engineering Center, Charles Stark Draper Laboratory, 555 Technology Square, Cambridge, MA 02139, United States of America; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA 0214, United States of America.
Biomedical Engineering Center, Charles Stark Draper Laboratory, 555 Technology Square, Cambridge, MA 02139, United States of America.
Eur J Pharm Sci. 2019 Jan 1;126:49-58. doi: 10.1016/j.ejps.2018.09.007. Epub 2018 Sep 7.
Measurement of drug distribution in the inner ear has important roles in the design of local delivery methods, such as direct, intracochlear delivery, and in assessment of emerging drug candidates in preclinical animal models. Sampling methods have been used in the past to measure drug concentrations in the cochlear fluids, but these methods provide no direct information about drug distribution in the cochlear tissues. In this work, we evaluated four fluorescent markers that simulate drug distribution in the organ of Corti after intracochlear delivery to the cochlea's scala tympani compartment. Our hypothesis is that ultimately, a cocktail comprising several fluorescent drug surrogates or fluorescently-tagged drugs, each with differing distribution, spreading, and clearance behavior, can be used to evaluate both transient and cumulative drug distributions associated with different delivery techniques. In this study, FITC-dextran, Qtracker™ 655, gentamicin Texas-Red, and FM 1-43 FX were each evaluated as candidate markers by direct intracochlear infusion into guinea-pig cochleae. Distribution of the markers was measured using fluorescence confocal microscopy imaging of cochlear whole mount dissections from animals sacrificed 3 h after the tracer-infusion. For all four tracers, strong fluorescence was observed in the tissue sections near the base, but only Qtracker™-655, gentamicin Texas-Red (GTTR) and FM 1-43 FX exhibited any specificity in labelling of the sensory hair cells. Therefore, these substances represent leading candidates for the quantification drug distribution achieved by different delivery approaches to the scala tympani.
内耳中药物分布的测量在局部递药方法的设计中具有重要作用,例如直接、内耳蜗内递药,以及在临床前动物模型中评估新兴药物候选物。过去曾使用采样方法来测量耳蜗液中的药物浓度,但这些方法无法提供关于耳蜗组织中药物分布的直接信息。在这项工作中,我们评估了四种荧光标记物,它们模拟了在内耳腔递药至耳蜗鼓阶腔后在耳蜗组织中的药物分布。我们的假设是,最终可以使用包含几种荧光药物模拟物或荧光标记药物的鸡尾酒,每种药物具有不同的分布、扩散和清除行为,来评估与不同递药技术相关的瞬态和累积药物分布。在这项研究中,FITC-葡聚糖、QtrackerTM 655、庆大霉素 Texas-Red 和 FM 1-43 FX 均通过直接在内耳腔输注到豚鼠耳蜗中来评估候选标记物。在牺牲后 3 小时进行的动物耳蜗整体解剖荧光共聚焦显微镜成像中测量了标记物的分布。对于所有四种示踪剂,在靠近基底的组织切片中观察到强烈的荧光,但只有 QtrackerTM-655、庆大霉素 Texas-Red (GTTR) 和 FM 1-43 FX 对感觉毛细胞具有特异性标记。因此,这些物质代表了用于定量不同给药方法至鼓阶所达到的药物分布的主要候选物。